William Grady
Fred Hutchinson Cancer Research Center
•Rodger C. Haggitt Professor of Medicine, Gastroenterology Division, University of Washington School of Medicine
•Professor, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center
•Co-Head of the GI Cancer Program of the Fred Hutchinson Cancer Center (FHCC)/University of Washington Comprehensive Cancer Center
•Medical Director of the GI Cancer Prevention Program Clinic at the Fred Hutchinson Cancer Center
•Dr. Grady is a cellular and molecular biologist and board-certified gastroenterologist.
•He is the contact PI of a multi-PI Early Detection Research Network (NCI) Biomarker Characterization Center; OncoAging Consortium Center and of a Translational Biology of Early Lesions (TBEL) Center.
•His NCI funded projects assess the role of epigenetic alterations as risk markers and biomarkers for esophageal and colon cancer, the role of genetic and epigenetic alterations in carcinogenesis, and age related mechanisms that affect colorectal cancer initiation and progression.
Appearances
DateMay 9, 2023Talks on the blood based screening test clinical trial results that will occur in 2022 and 2023 (ECLIPSE, PREEMPT, BLUE-C) and effects on clinical care; updates on multi-cancer early detection test; emerging screening tests (Oncoguard, Colonosight, etc)…Presenter
Fred Hutchinson Cancer Research Center- DateMay 9, 2023Talks on the blood based screening test clinical trial results that will occur in 2022 and 2023 (ECLIPSE, PREEMPT, BLUE-C) and effects on clinical care; updates on multi-cancer early detection test; emerging screening tests (Oncoguard, Colonosight, etc)…
Presenters
Fred Hutchinson Cancer Research CenterUniversity of Michigan 
DateMay 9, 2023SOCIETY: AGAModerators
Mayo ClinicFred Hutchinson Cancer Research Center- DateMay 9, 2023BACKGROUND: Gut dysbiosis is associated with persistent multi-system symptoms following SARS-CoV-2 infection, or post-acute COVID-19 syndrome (PACS). We performed a randomised controlled trial to assess the effects of gut microbiome modulation on alleviation of PACS symptoms…
Presenter
Speakers
University of California San DiegoFred Hutchinson Cancer CenterFred Hutchinson Cancer Research Center - DateMay 18, 2024
Presenter
Fred Hutchinson Cancer Research Center - DateMay 21, 2024
Presenter
Fred Hutchinson Cancer Research Center - DateMay 21, 2024
Presenters
- DateMay 20, 2024
Presenter
Fred Hutchinson Cancer Research Center 
DateMay 18, 2024SOCIETY: AGA Advances in technology and our understanding of pathogenesis of GI malignancies are leading to innovations in screening and surveillance strategies. In this session we will learn about emerging technologies for BE screening and risk stratification…Moderators
Oregon Health and Science UniversityUniversity of KansasSpeakers
DateMay 5, 2025LIVE STREAM SESSION This session will review the science behind multi-cancer early detection tests, approaches t clinical validation and dissemination…Moderators
Fred Hutchinson Cancer Research CenterUniversity of Chicago- DateMay 3, 2025
Speakers
Fred Hutchinson Cancer Research CenterIndiana University School of Medicine
